26
Views
5
CrossRef citations to date
0
Altmetric
Review

The new generation of anti-epileptic drugs

Pages 87-106 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrew Fisher, Joanna M Zakrzewska & Philip N Patsalos. (2003) Trigeminal neuralgia: current treatments and future developments. Expert Opinion on Emerging Drugs 8:1, pages 123-143.
Read now

Articles from other publishers (4)

Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 155 177 .
Ming Liu, Qiangsan Wu & Wenxiang Hu. (2011) Pharmacophore Screening on Piperidinecarboxamides Derivatives Based on GALAHAD and CoMFA Models. Chinese Journal of Chemistry 29:6, pages 1075-1083.
Crossref
Eleonora Ghidini, Maurizio Delcanale, Renato De Fanti, Andrea Rizzi, Manuela Mazzuferi, Donata Rodi, Michele Simonato, Milco Lipreri, Franco Bassani, Loredana Battipaglia, Marco Bergamaschi & Gino Villetti. (2006) Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives. Bioorganic & Medicinal Chemistry 14:10, pages 3263-3274.
Crossref
X Tong & P N Patsalos. (2001) A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain. British Journal of Pharmacology 133:6, pages 867-874.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.